Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | JAK3 | P52333 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | DHFR | P00374 | 1/20 | 0.38 |
| ▸ | TYMS | P04818 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7843188 | 0.85 | NAMPT (0.57) | NAMPTLMNACYP1A2CYP3A4MAOA | |
| SCHEMBL9042181 | 0.83 | DHFR (0.54) | DHFRTYMS | |
| SCHEMBL9042192 | 0.83 | DHFR (0.54) | DHFRTYMS | |
| SCHEMBL9044536 | 0.83 | NAMPT (0.51) | NAMPTLMNACYP1A2CYP3A4MAOA | |
| SCHEMBL9039595 | 0.82 | DHFR (0.52) | NAMPTLMNADHFR | |
| SCHEMBL9043791 | 0.82 | LMNA (0.38) | JAK2JAK3LMNACYP1A2CYP3A4 | |
| SCHEMBL9042512 | 0.81 | NAMPT (0.43) | NAMPTLMNACYP1A2CYP3A4MAOA | |
| SCHEMBL9042675 | 0.77 | DHFR (0.66) | LMNADHFRTYMS | |
| SCHEMBL9044792 | 0.76 | TYMS (0.51) | NAMPTLMNACYP1A2CYP3A4MAOA | |
| SCHEMBL9047680 | 0.74 | DHFR (0.45) | NAMPTLMNACYP1A2CYP3A4MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0400562-B1 | Pyrrolopyrimidines, their production and use as tumoricidal agents | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1996-08-21 | — | — | EP | disclosed |